Donor Screening: HBsAg , HCV, HIV, HBc,VDRL, MP, HB + (only for stat lab) at Chughtai Lab

Donor Screening: HBsAg , HCV, HIV, HBc,VDRL, MP, HB + (only for stat lab) at Chughtai Lab

Blood transfusion is a life-saving medical intervention, but it carries inherent risks of transmitting infectious diseases. To ensure recipient safety, diagnostic centers utilize rigorous screening protocols. The Donor Screening: HBsAg , HCV, HIV, HBc,VDRL, MP, HB + (only for stat lab) at Chughtai Lab is a comprehensive, highly specialized panel designed to evaluate the safety and eligibility of blood donors. This panel screens for major transfusion-transmissible infections (TTIs) and assesses the donor's physiological capacity to donate blood. By combining highly sensitive serological assays with rapid hematological testing, this panel serves as a critical line of defense in clinical transfusion medicine across Pakistan.

This screening panel evaluates several key infectious markers and physiological parameters. It includes tests for Hepatitis B Surface Antigen (HBsAg), Hepatitis C Virus (HCV) antibodies, Human Immunodeficiency Virus (HIV) antibodies and antigens, Hepatitis B Core Antibody (HBc), Venereal Disease Research Laboratory (VDRL) test for syphilis, Malarial Parasite (MP) identification, and Hemoglobin (HB) estimation. The inclusion of the Hemoglobin test under the "only for stat lab" designation ensures that in emergency or rapid-response settings, the donor's oxygen-carrying capacity is immediately verified alongside their infectious disease status. This prevents the collection of blood from anemic individuals, protecting both the donor from severe fatigue and the recipient from receiving sub-optimal blood products.

Chughtai Lab utilizes state-of-the-art chemiluminescent immunoassay (CLIA) technology, rapid diagnostic tests (RDTs), and automated hematology analyzers to perform these evaluations. The anatomical focus of this test is systemic, evaluating the donor's peripheral blood for circulating viral antigens, host antibodies, intraerythrocytic parasites, and overall red blood cell parameters. The clinical importance of this panel cannot be overstated; it minimizes the risk of post-transfusion hepatitis, retroviral transmission, systemic bacterial infections like syphilis, and parasitic infections like malaria. It provides immense diagnostic value to hematologists, transfusion specialists, and transplant surgeons, ensuring that every unit of blood transfused meets international safety guidelines.

Clinical Procedure: What to Expect

Patient Preparation

Proper preparation is essential to ensure accurate results and a safe donation process. Donors undergoing the Donor Screening: HBsAg , HCV, HIV, HBc,VDRL, MP, HB + (only for stat lab) at Chughtai Lab should adhere to the following guidelines:

• Hydration: Drink plenty of water or non-alcoholic fluids starting 24 hours before the test to maintain blood volume and facilitate easy venipuncture.
• Dietary Intake: Eat a healthy, low-fat meal within 2 to 4 hours of the screening. Avoid donating on an empty stomach to prevent dizziness or vasovagal syncope.
• Rest: Ensure at least 6 to 8 hours of sleep the night before the screening.
• Medication Disclosure: Inform the healthcare staff of all prescription medications, over-the-counter drugs, and herbal supplements currently being taken.
• Identification and History: Bring a valid government-issued identification card. Be prepared to fill out a detailed donor history questionnaire regarding travel, medical history, tattoos, piercings, and lifestyle factors.
• Avoid Stimulants: Refrain from smoking for at least 2 to 4 hours and avoid alcohol consumption for 24 hours prior to the screening.

During the Procedure

The collection of samples for this screening panel is performed by highly trained phlebotomists at Chughtai Lab. The procedure is designed to be quick, sterile, and comfortable:

• Donor Positioning: The donor is seated comfortably in a specialized donor chair or asked to lie down on a donor bed.
• Site Selection and Preparation: The phlebotomist identifies a suitable vein, typically the median cubital vein in the antecubital fossa. The skin is thoroughly cleansed with an antiseptic solution (such as chlorhexidine or isopropyl alcohol) using a circular motion to prevent bacterial contamination of the sample.
• Venipuncture: A sterile, single-use needle is inserted into the vein. For the infectious disease serology, blood is collected in serum separator tubes (SST), while an EDTA tube is used for the Hemoglobin and Malarial Parasite evaluations.
• Duration: The actual blood draw takes approximately 5 to 10 minutes.
• Post-Collection Care: Once the required volume is collected, the needle is gently removed, and immediate pressure is applied to the puncture site with a sterile gauze pad. A bandage is applied, and the donor is advised to keep it on for at least several hours.
• Recovery: The donor is monitored for a few minutes and provided with light refreshments to help restore blood sugar levels and fluid volume.

When is a Donor Screening: HBsAg , HCV, HIV, HBc,VDRL, MP, HB + (only for stat lab) Performed?

Routine Voluntary and Directed Blood Donation

This comprehensive screening panel is routinely performed whenever an individual volunteers to donate blood or when a family member provides a directed donation for a specific patient. It is a mandatory regulatory requirement to screen every unit of donated blood before it can be processed into components (such as packed red blood cells, fresh frozen plasma, or platelets) and cleared for transfusion. This process ensures that the blood supply remains free of highly infectious pathogens.

Emergency and Stat Transfusion Scenarios

In acute clinical emergencies, such as severe trauma, massive postpartum hemorrhage, or ruptured aortic aneurysms, blood must be prepared and transfused with extreme urgency. The "only for stat lab" protocol of this panel is activated in these high-pressure situations. The stat lab prioritizes these samples, utilizing rapid diagnostic methodologies to screen the donor's blood for critical viral markers and immediately verify their hemoglobin levels, allowing for the rapid and safe release of compatible blood units.

Pre-Operative Autologous Blood Donation

Patients scheduled for major elective surgeries, such as orthopedic joint replacements or cardiothoracic procedures, may choose to donate their own blood weeks in advance to be stored for potential use during their surgery. This is known as autologous donation. Even though the blood is intended for the patient's own use, this donor screening panel is performed to identify any underlying infections, manage clinical risks, and prevent accidental cross-contamination within the blood bank storage facilities.

Occult Hepatitis B Infection Surveillance

The inclusion of the Hepatitis B Core Antibody (HBc) test in this panel is particularly crucial for identifying occult Hepatitis B infections. Some donors may test negative for the Hepatitis B Surface Antigen (HBsAg) but still carry the virus in a latent state, which can be transmitted through transfusion. Testing for anti-HBc allows clinicians to detect past or chronic infections, providing an extra layer of safety that standard HBsAg testing might miss, especially in regions with a high prevalence of Hepatitis B.

Therapeutic Apheresis and Specialized Donor Programs

Individuals participating in specialized donor programs, such as plateletpheresis or plasmapheresis, undergo this screening regularly. Because these procedures involve returning certain blood components back to the donor while retaining others, continuous monitoring of the donor's infectious status and hemoglobin levels is vital to protect both the donor's health and the integrity of the collected apheresis products.

What Does a Donor Screening: HBsAg , HCV, HIV, HBc,VDRL, MP, HB + (only for stat lab) Detect?

This multi-parametric panel is designed to detect a wide array of clinical markers, infectious agents, and physiological states. Specifically, the test evaluates and detects:

• Hepatitis B Surface Antigen (HBsAg): Indicates active, acute, or chronic infection with the Hepatitis B virus.
• Hepatitis C Virus (HCV) Antibodies: Detects exposure to the Hepatitis C virus, indicating active or past infection.
• HIV-1 and HIV-2 Antibodies: Identifies the presence of antibodies produced by the body in response to Human Immunodeficiency Virus types 1 and 2.
• HIV p24 Antigen: Allows for early detection of HIV infection during the window period before antibodies are fully developed.
• Hepatitis B Core Antibody (HBc Total): Detects total antibodies (IgG and IgM) against the core antigen of HBV, identifying occult or resolved infections.
• Treponema pallidum Antibodies (VDRL): Screens for active or latent syphilis, a sexually and transfusion-transmissible bacterial infection.
• Plasmodium falciparum Parasites: Identifies the presence of the most severe malaria-causing parasite in the blood.
• Plasmodium vivax Parasites: Detects the parasite responsible for relapsing malaria, highly prevalent in South Asia.
• Plasmodium malariae and ovale: Screens for less common species of the malaria parasite.
• Donor Anemia: Identified via low hemoglobin levels, indicating that the donor is unfit to donate.
• Polycythemia: Abnormally high hemoglobin levels, which may require clinical evaluation.
• Occult Hepatitis B Carrier State: Indicated by a positive HBc result despite a negative HBsAg.
• Early Window Period Infections: Highlights the risk of very recent viral exposures that may not yet show reactive antibody levels.
• False-Positive VDRL Reactions: Can occur due to pregnancy, autoimmune diseases, or other acute infections.
• Active Parasitemia: Confirms the presence of circulating malarial gametocytes or trophozoites.
• Inadequate Oxygen-Carrying Capacity: Low hemoglobin levels that would compromise recipient recovery.
• Co-infections: Simultaneous presence of multiple pathogens, such as HIV and HCV.
• Serum Lipemia: Excess lipids in the blood sample that may interfere with optical testing methods.
• Hemolysis in Sample: Damaged red blood cells in the test tube, necessitating a repeat sample.
• Non-Reactive Status: Confirms the absence of detectable levels of the screened pathogens, indicating a suitable donor profile.

Turnaround Time and Report Access at Chughtai Lab

Chughtai Lab is committed to delivering accurate diagnostic reports with optimal efficiency. For the Donor Screening: HBsAg , HCV, HIV, HBc,VDRL, MP, HB + (only for stat lab), the turnaround time depends on the clinical urgency. When ordered under the "Stat" protocol, results for critical parameters such as Hemoglobin, Malarial Parasite, and rapid viral screens are prioritized and typically completed within 2 to 4 hours. Standard, non-emergency donor screening panels are processed using fully automated high-throughput systems, with comprehensive reports generally available within 12 to 24 hours.

Patients and healthcare providers can access reports easily through Chughtai Lab's advanced digital infrastructure. Reports can be downloaded directly from the official Chughtai Lab website by entering the patient ID and case number. Additionally, the My Chughtai App, available on iOS and Android platforms, provides real-time notifications when reports are ready and allows users to view, download, and share their diagnostic history. For added convenience, printed reports can be collected from any Chughtai Lab collection center or delivered directly to the patient's registered address.

Donor Screening: HBsAg , HCV, HIV, HBc,VDRL, MP, HB + (only for stat lab) Findings Overview

Structure / Parameter Evaluated	Normal Findings	Possible Abnormal Findings
HBsAg (Hepatitis B Surface Antigen)	Non-Reactive (Negative)	Reactive (Positive) – Indicates active HBV infection
Anti-HCV (Hepatitis C Antibodies)	Non-Reactive (Negative)	Reactive (Positive) – Indicates exposure to HCV
Anti-HIV 1/2 & p24 Antigen	Non-Reactive (Negative)	Reactive (Positive) – Indicates HIV infection
Anti-HBc (Hepatitis B Core Antibody)	Non-Reactive (Negative)	Reactive (Positive) – Indicates past or occult HBV
VDRL (Syphilis Screening)	Non-Reactive (Negative)	Reactive (Positive) – Suggests Treponema infection
Malarial Parasite (MP)	Not Detected (Negative)	Detected (Positive) – Presence of Plasmodium species
Hemoglobin (HB)	Male: 13.5 – 17.5 g/dL; Female: 12.0 – 15.5 g/dL	Low (<12.0 g/dL) – Anemia; High (>18.0 g/dL) – Polycythemia

Note: Diagnostic findings should always be interpreted by a qualified healthcare professional together with the patient's symptoms, medical history, physical examination, laboratory investigations, previous imaging studies, and other relevant clinical information. Additional investigations or specialist consultation may be recommended depending on the findings.

Why Choose Chughtai Lab for Donor Screening: HBsAg , HCV, HIV, HBc,VDRL, MP, HB + (only for stat lab)?

• Experienced Healthcare Professionals: Our team consists of highly qualified pathologists, hematologists, and technologists dedicated to diagnostic excellence.
• Patient-Focused Care: We prioritize donor comfort, safety, and confidentiality throughout the screening and collection process.
• Quality Diagnostic Services: Chughtai Lab adheres to stringent international quality control standards, ensuring highly reliable test results.
• Professional Reporting: Clear, comprehensive, and easy-to-understand reports designed to assist clinicians in rapid decision-making.
• Modern Diagnostic Approach: Utilizing state-of-the-art automated immunoassay systems and hematology analyzers for precise detection.
• Comfortable Environment: Our collection centers and donor lounges are designed to provide a clean, sterile, and relaxing experience.
• Convenient Location: With an extensive network of diagnostic centers across Pakistan, finding a Chughtai Lab near you is simple.
• Commitment to Accurate Diagnosis: We employ robust internal and external quality assurance programs to eliminate testing errors.